• OPEN AN ACCOUNT
Indian Indices
Sensex
72,529.07 -242.65
( -0.33%)
Global Indices
Nasdaq
51,510.98 -338.64
(-0.65%)
Dow Jones
7,705.40 -59.01
(-0.76%)
Hang Seng
65,155.57 -722.05
(-1.10%)
Nikkei 225
10,700.56 5.31
(0.05%)
Forex
USD-INR
95.79 -0.10
(-0.10%)
EUR-INR
109.09 0.01
(0.01%)
GBP-INR
126.83 0.01
(0.01%)
JPY-INR
0.61 0.00
(0.68%)

EQUITY - MARKET SCREENER

Huhtamaki India Ltd
Industry :  Packaging
BSE Code
ISIN Demat
Book Value()
509820
INE275B01026
178.6016744
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HUHTAMAKI
12.97
1769.1
EPS(TTM)
Face Value()
Div & Yield %
18.06
2
0.85
 

RPG Life Sciences appoints Deepak Shukla as CEO of RPG Active Pharma
Aug 15,2026
RPG Life Sciences announced that Deepak Shukla, Chief Executive - API Business, has ceased to be a Senior Management Personnel of the Company, with effect from the close of business hours on 14 August 2026, consequent upon his appointment as Chief Executive Officer in capacity of Key Managerial Personnel of RPG Active Pharma, a wholly-owned subsidiary of the Company with effect from 15 August 2026.